Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03873467 · ClinicalTrials.gov registry record · NA

Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)

A NA study of Stroke, sponsored by Baylor Research Institute.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT03873467 is a NA study of Stroke that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 65 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03873467, a NA study of Stroke, is active but no longer recruiting, sponsored by Baylor Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.

Conditions Studied

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Group Lifestyle Balance

Study Locations (1)

Texas

  • Baylor Scott & White Institute for Rehabilitation - Dallas

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2019-07-08
Est. Completion 2026-12-30
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT03873467

The ClinicalTrials.gov registry entry for NCT03873467 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT03873467 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03873467 about?

NCT03873467 is a clinical study titled "Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)". The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.

What is the current status of trial NCT03873467?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2019-07-08. Estimated completion is 2026-12-30.

What conditions does trial NCT03873467 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT03873467?

The interventions under investigation include: Usual Care (OTHER), Group Lifestyle Balance (BEHAVIORAL).

Who is sponsoring clinical trial NCT03873467?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03873467 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.